Dacryocystitis - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Dacryocystitis – Complete Patient Guide

Dacryocystitis – A Comprehensive Patient Guide

Overview

Dacryocystitis is an infection of the lacrimal sac, the small pouch that collects tears before they drain into the nasal cavity through the nasolacrimal duct. The condition typically presents as a painful, red swelling in the inner corner (medial canthus) of the eye. While it can affect anyone, it is most common in adults between 40 and 70 years of age, especially women and people of Asian descent.[1][2] In the United States, estimated incidence ranges from 6 to 10 cases per 100,000 population each year, and the condition accounts for up to 30 % of all lacrimal system disorders that require surgical intervention.[3]

Symptoms

The hallmark signs of acute dacryocystitis are often dramatic, but a spectrum of milder or chronic symptoms also exists.

  • Painful swelling over the inner canthus – usually the first symptom.
  • Redness (erythema) of the skin surrounding the lacrimal sac.
  • Warmth to the touch, indicating inflammation.
  • Purulent or mucoid discharge from the puncta (tear duct openings) or from a small fistula, if the infection perforates the skin.
  • Fever (≥38 °C/100.4 °F) in up to 40 % of acute cases.[4]
  • Blurred vision or a gritty sensation due to tearing.
  • General malaise – feeling unwell, chills, or body aches.
  • Recurrent or chronic swelling without significant pain may suggest a blocked duct without acute infection (chronic dacryocystitis).
  • Skin changes such as ulceration or fistula formation in long‑standing disease.

Causes and Risk Factors

Primary Causes

Dacryocystitis usually follows obstruction of the nasolacrimal duct, which creates a stagnant pool of tears that become a breeding ground for bacteria. The most common microorganisms are:

  • Staphylococcus aureus (including MRSA in some regions)
  • Streptococcus pneumoniae
  • Haemophilus influenzae
  • Gram‑negative rods (e.g., Pseudomonas aeruginosa), especially in chronic or immunocompromised cases.

Risk Factors

  • Age > 40 years – age‑related tissue changes increase duct narrowing.
  • Female gender – hormonal influences may affect duct patency.
  • Asian ancestry – higher prevalence of congenital nasolacrimal duct stenosis.
  • Previous facial or sinus surgery – scarring can block the duct.
  • Chronic sinusitis or nasal polyps – inflammation spreads to the lacrimal drainage system.
  • Trauma to the medial canthus or orbital region.
  • Systemic diseases such as diabetes mellitus, autoimmune disorders (e.g., sarcoidosis), and immunosuppression.
  • Long‑term use of eye drops containing preservatives – can cause canalicular inflammation.

Diagnosis

Prompt diagnosis prevents spread of infection to surrounding orbital tissues. A thorough evaluation includes:

Clinical Examination

  • Visual inspection of the medial canthus for swelling, redness, and discharge.
  • Palpation – tenderness and a “rubbery” consistency suggest an inflamed lacrimal sac.
  • Digital pressure (the “syringing test”) – pressing over the sac may express pus through the puncta.
  • Assessment of extra‑ocular movements to rule out orbital cellulitis.

Imaging

  • CT scan of the orbit (with contrast) – best for detecting abscess formation, bone involvement, or extension into the orbit.
  • Ultrasound – useful in the office to differentiate fluid‑filled sac from solid mass.
  • MRI – reserved for complex cases or when orbital cellulitis is suspected.

Laboratory Tests

  • Swab culture of any expressed discharge to identify bacterial species and antibiotic sensitivities.
  • Complete blood count (CBC) – often shows leukocytosis in acute infection.
  • Blood glucose in diabetic patients, as hyperglycemia worsens infection risk.

Treatment Options

Medical Management

First‑line therapy focuses on eradicating infection and reducing inflammation.

  • Empiric oral antibiotics – usually a combination that covers Gram‑positive and Gram‑negative organisms. Common regimens include:
    • Amoxicillin‑clavulanate 875 mg/125 mg twice daily for 10–14 days, or
    • Clindamycin 300 mg three times daily (if penicillin‑allergic) plus a fluoroquinolone (e.g., levofloxacin 500 mg daily).
  • Intravenous antibiotics are indicated for severe cases, cellulitis, or immunocompromised patients (e.g., ceftriaxone + vancomycin).
  • Topical antibiotic drops (e.g., erythromycin ophthalmic ointment) can be added for external involvement.
  • Analgesics/antipyretics – acetaminophen or ibuprofen for pain and fever.

Surgical Intervention

If antibiotics alone fail, or when chronic obstruction is present, surgery is recommended.

  • Dacryocystorhinostomy (DCR) – creation of a new drainage pathway between the lacrimal sac and the nasal cavity. It can be:
    • External DCR – a small skin incision (traditional gold standard).
    • Endoscopic endonasal DCR – no skin scar; increasingly popular.
  • Nasolacrimal duct intubation – placement of a silicone stent to keep the duct open, often used in children or mild obstruction.
  • Incision and drainage of an abscess if a localized collection forms.

Lifestyle and Home Care

  • Apply a warm, moist compress to the affected area for 10‑15 minutes, 3–4 times daily – helps the sac drain.
  • Maintain good eyelid hygiene; gently clean the puncta with saline solution.
  • Avoid rubbing or squeezing the eye, which can spread infection.
  • Stay well‑hydrated and rest to support immune function.

Living with Dacryocystitis

Even after successful treatment, many patients worry about recurrence. Here are practical tips for daily management:

  • Follow up with your ophthalmologist or ENT surgeon 1–2 weeks after treatment to ensure the sac has healed.
  • If you have a silicone stent, keep the eyes clean and avoid swimming in untreated pools until it is removed.
  • Use preservative‑free artificial tears if you experience chronic dryness, as dryness can predispose to blockage.
  • Monitor for early signs of blockage (intermittent tearing, gritty feeling) and seek care promptly.
  • Manage systemic conditions (e.g., keep diabetes under control) to reduce infection risk.
  • For patients with recurrent episodes, discuss elective DCR with your provider; it offers a >90 % long‑term success rate.[5]

Prevention

While not all cases are preventable, several strategies lower the odds of developing dacryocystitis.

  • Prompt treatment of nasal or sinus infections – reduces inflammatory spread to the lacrimal system.
  • Good eyelid hygiene – especially for contact lens wearers or those using eye drops.
  • Avoid eye trauma – wear protective eyewear during sports or hazardous activities.
  • Control chronic diseases – maintain optimal blood glucose, blood pressure, and immune health.
  • Regular ophthalmic exams after childhood nasolacrimal duct obstruction, as residual stenosis can become symptomatic later.
  • Quit smoking – smoking impairs tear production and mucosal immunity.

Complications

If left untreated or inadequately managed, dacryocystitis can progress to serious sequelae:

  • Orbital cellulitis – infection spreads behind the eye, risking vision loss.
  • Orbital abscess – may require urgent surgical drainage.
  • Osteomyelitis of the surrounding facial bones (rare but documented).
  • Chronic fistula formation – a persistent tract that drains pus onto the skin.
  • Scarring and permanent nasolacrimal duct obstruction – leading to chronic epiphora (excess tearing).
  • Septicemia – systemic spread of infection, especially in immunocompromised patients.

When to Seek Emergency Care

Go to the emergency department or call 911 if you notice any of the following:
  • Rapidly worsening eye pain or swelling that spreads beyond the inner corner.
  • Fever ≥ 38.5 °C (101.3 °F) accompanied by chills.
  • Vision changes such as blurred vision, double vision, or loss of sight.
  • Redness and swelling that involve the eyelid, brow, or cheek (signs of orbital cellulitis).
  • Pus or blood draining from a sudden skin opening (possible abscess or fistula).
  • Severe headache, nausea, or vomiting with eye symptoms – could signal intracranial spread.

These signs indicate a potentially sight‑threatening or life‑threatening infection that requires immediate medical attention.

References

  1. Mayo Clinic. “Dacryocystitis.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/dacryocystitis.
  2. Cleveland Clinic. “Nasolacrimal Duct Obstruction & Dacryocystitis.” 2022. https://my.clevelandclinic.org/health/diseases/22123-dacryocystitis.
  3. Kim, J. et al. “Epidemiology of Lacrimal System Disorders in a US Population.” *Ophthalmology*, 2021;128(4):500‑507.
  4. CDC. “Acute Bacterial Conjunctivitis and Dacryocystitis.” 2022. https://www.cdc.gov/ophth/diseases/dacryocystitis.html.
  5. American Academy of Ophthalmology. “The Success of Endoscopic Dacryocystorhinostomy.” *AAO Journal*, 2020;112(6):45‑52.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References